Pretransplant CD8 T-cell response to IE-1 discriminates seropositive kidney recipients at risk of developing CMV infection posttransplant

Transplantation

Volumn 97, Issue 8, 2014, Pages 839-845

  López Oliva, Maria Ovidia ^a   Martinez, Virginia ^a   Buitrago, Águeda ^a   Jiménez, Carlos ^a   Rivas, Begoña ^a   Escuin, Fernando ^a   Santana, María José ^a   Selgas, Rafael ^a   Bellón, Teresa ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Cytokine flow cytometry; Cytomegalovirus; IFN gamma; Immune monitoring; Intracellular flow cytometry; Kidney transplant; Peptides; T cells

Indexed keywords

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS INFECTIONS; EPITOPES; FEMALE; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERFERON-GAMMA; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PHOSPHOPROTEINS; PREOPERATIVE PERIOD; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; VIRAL MATRIX PROTEINS;

EID: 84899477809     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000438025.96334.eb     Document Type: Article

References (27)

1. Humar A, Snydman D. Cytomegalovirus in solid organ transplantrecipients. Am J Transplant 2009; 9(Suppl 4): S78.
2. Kotton CN. CMV: prevention, diagnosis and therapy. Am J Transplant2013; 13(Suppl 3): 24.
3. Jackson SE, Mason GM, Wills MR. Human cytomegalovirus immunityand immune evasion. Virus Res 2011; 157: 151.
4. Rook AH. Interactions of cytomegalovirus with the human immunesystem. Rev Infect Dis 1988; 10(Suppl 3): S460.
5. Harari A, Zimmerli SC, Pantaleo G. Cytomegalovirus (CMV)-specificcellular immune responses. Hum Immunol 2004; 65: 500.
6. Egli A, Humar A, Kumar D. State-of-the-art monitoring ofcytomegalovirus-specific cell-mediated immunity after organ transplant:a primer for the clinician. Clin Infect Dis 2012; 55: 1678.
7. Gamadia LE, Remmerswaal EB, Weel JF, et al. Primary immune responsesto human CMV: a critical role for IFN-gamma-producingCD4+ T cells in protection against CMV disease. Blood 2003; 101: 2686.
8. Sester U, Gartner BC,Wilkens H, et al. Differences in CMV-specific Tcelllevels and long-term susceptibility to CMV infection after kidney,heart and lung transplantation. Am J Transplant 2005; 5: 1483.
9. Gerna G, Lilleri D, Fornara C, et al. Monitoring of humancytomegalovirus- specific CD4 and CD8 T-cell immunity in patientsreceiving solid organ transplantation. Am J Transplant 2006; 6: 2356.
10. Egli A, Binet I, Binggeli S, et al. Cytomegalovirus-specific T-cell responsesand viral replication in kidney transplant recipients. J TranslMed 2008; 6: 29.
11. Gerna G, Lilleri D, Chiesa A, et al. Virologic and immunologicmonitoring of cytomegalovirus to guide preemptive therapy in solidorgantransplantation. Am J Transplant 2011; 11: 2463.
12. Bunde T, Kirchner A, Hoffmeister B, et al. Protection from cytomegalovirusafter transplantation is correlated with immediate early1-specific CD8 T cells. J Exp Med 2005; 201: 1031.
13. Crough T, Fazou C, Weiss J, et al. Symptomatic and asymptomaticviral recrudescence in solid-organ transplant recipients and its relationshipwith the antigen-specific CD8(+) T-cell response. J Virol2007; 81: 11538.
14. Lacey SF, La Rosa C, Zhou W, et al. Functional comparison of T cellsrecognizing cytomegalovirus pp65 and intermediate-early antigenpolypeptides in hematopoietic stem-cell transplant and solid organtransplant recipients. J Infect Dis 2006; 194: 1410.
15. Lilleri D, Zelini P, Fornara C, et al. Inconsistent responses ofcytomegalovirus-specific T cells to pp65 and IE-1 versus infected dendriticcells in organ transplant recipients. Am J Transplant 2007; 7: 1997.
16. Christmas SE, Halliday D, Lawton N, et al. Cytomegalovirus-specificCD8+ T cells do not develop in all renal transplant patients at risk ofvirus infection. Transpl Immunol 2009; 22: 99.
17. Foster AE, Gottlieb DJ, Sartor M, et al. Cytomegalovirus-specificCD4+ and CD8+ T-cells follow a similar reconstitution pattern afterallogeneic stem cell transplantation. Biol Blood Marrow Transplant2002; 8: 501.
18. Sinclair E, Black D, Epling CL, et al. CMVantigen-specific CD4+ andCD8+ T cell IFNgamma expression and proliferation responses inhealthy CMV-seropositive individuals. Viral Immunol 2004; 17: 445.
19. Khan N, Best D, Bruton R, et al. T cell recognition patterns ofimmunodominant cytomegalovirus antigens in primary and persistentinfection. J Immunol 2007; 178: 4455.
20. Cantisan S, Lara R, Montejo M, et al. Pretransplant interferon- gammasecretion by CMV-specific CD8+ T cells informs the risk of CMVreplication after transplantation. Am J Transplant 2013; 13: 738.
21. Simon CO, Holtappels R, Tervo HM, et al. CD8 T cells control cytomegaloviruslatency by epitope-specific sensing of transcriptionalreactivation. J Virol 2006; 80: 10436.
22. Seckert CK, Griessl M, Buttner JK, et al. Viral latency drives 'memoryinflation': a unifying hypothesis linking two hallmarks of cytomegalovirusinfection. Med Microbiol Immunol 2012; 201: 551.
23. Ameres S, Mautner J, Schlott F, et al. Presentation of an immunodominantimmediate-early CD8+ T cell epitope resists human cytomegalovirusimmunoevasion. PLoS Pathog 2013; 9: e1003383.
24. Boeckh M, Huang M, Ferrenberg J, et al. Optimization of quantitativedetection of cytomegalovirus DNA in plasma by real-time PCR. J ClinMicrobiol 2004; 42: 1142.
25. Sis B, Mengel M, Haas M, et al. Banff '09 meeting report: antibodymediated graft deterioration and implementation of Banff workinggroups. Am J Transplant 2010; 10: 464.
26. Kotton CN, Kumar D, Caliendo AM, et al. International consensusguidelines on the management of cytomegalovirus in solid organtransplantation. Transplantation 2010; 89: 779.
27. Zhou W, Longmate J, Lacey SF, et al. Impact of donor CMV statuson viral infection and reconstitution of multifunction CMVspecificT cells in CMV-positive transplant recipients. Blood 2009;113: 6465.